Bison Wealth LLC Takes Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bison Wealth LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,524 shares of the exchange traded fund’s stock, valued at approximately $225,000.

Several other large investors have also recently bought and sold shares of the stock. JPMorgan Chase & Co. increased its holdings in shares of SPDR S&P Biotech ETF by 179.1% during the 1st quarter. JPMorgan Chase & Co. now owns 7,534,471 shares of the exchange traded fund’s stock worth $574,202,000 after purchasing an additional 4,835,071 shares during the period. Jane Street Group LLC lifted its position in shares of SPDR S&P Biotech ETF by 111.4% in the 2nd quarter. Jane Street Group LLC now owns 172,730 shares of the exchange traded fund’s stock worth $12,829,000 after acquiring an additional 1,682,382 shares during the period. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $102,900,000. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of SPDR S&P Biotech ETF by 103.3% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock valued at $129,318,000 after purchasing an additional 900,000 shares during the period. Finally, Squarepoint Ops LLC acquired a new position in shares of SPDR S&P Biotech ETF in the first quarter valued at $34,666,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $84.65 on Thursday. The stock has a market cap of $6.58 billion, a P/E ratio of 11.47 and a beta of 1.08. The stock has a fifty day moving average price of $93.79 and a 200 day moving average price of $84.13. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.